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Melanotic neuroectodermal tumour of infancy (MNTI) is an uncommon pigmented 
neoplasm of neural crest origin. The term “melanotic neuroectodermal tumour of infancy” 
was introduced for the first time in 1966 1 . Although it is generally agreed upon that it is 
a benign entity, it is locally aggressive and has a significant recurrent risk, reported to be 
between 10-15% 2. There have also been prior reports of malignant behaviour in these 
tumours, although extremely rare. The majority of cases (about 70%) arise from the maxilla 
and only approximately 15.6% arise from the cranial vault 3. Patients often present with 
rapidly growing soft tissue mass that displaces rather than infiltrate adjacent structures. The 
main imaging differential diagnoses for a cranial vault mass in infants, aside from MNTI, 
would include metastatic neuroblastoma, Langerhans’ cell histiocytosis (LCH), Ewing 
sarcoma, intradiploic cavernous hemangioma and intracranial infantile 
hemangiopericytoma (HPC) 4,5. Herein, we describe a rare case of MNTI, with 
simultaneous involvement of the cranial vault and petrous temporal bone, in a four-month-
old child, complicated by post-surgical encephalocele. This case illustrates the diagnostic 
dilemma in differentiating reactive osseous sclerosis in surrounding bone (in this case, the 
left petrous temporal bone) from direct tumour infiltration, both of which can occur in the 
context of MNTI. Follow-up scan one year after surgery showed interval reduction in the 
extent of osseous sclerosis within the left petrous temporal bone, in keeping with reactive 
sclerosis and less likely to represent residual tumour. The discussion emphasizes on 
differential diagnoses and useful radiological features to assist in clinching the diagnosis 
of MNTI.  




A 4-month old child presented with a rapidly growing lump behind her left ear. The 
child was otherwise well. Physical examination revealed a bony lump with no evidence of 
overlying inflammatory skin changes. Neurological examination was also unremarkable. 
No dysmorphic features were noted.  
Skull radiographs were acquired and showed a sclerotic lesion in the left parieto-
occipito-temporal cranial vault (Figure 1a,b). Computed tomography (CT) and magnetic 
resonance imaging (MRI) of the head were subsequently performed for further lesion 
characterization. CT demonstrated a solitary osseous-based lesion with marked spiculated 
periosteal reaction and mildly hyperdense soft tissue component abutting the inner and 
outer tables of the left cranial vault (Figure 1c,d). On MRI, the soft tissue component 
showed hyperintense signal on T1-weighted images and mildly hypointense signal on T2-
weighted images. Mass effect upon the underlying left temporo-parietal lobes was 
observed with mild vasogenic oedema within the left temporal lobe (Figure 2).  
The patient was referred to the neurosurgical team with view for biopsy of the left 
calvarial lesion. Biopsy was performed and a histopathological diagnosis of MNTI was 
made. The patient was then scheduled for surgical excision of the tumour. The surgery was 
uneventful and patient recovered well with no focal neurological deficits. A large calvarial 
defect was present after the surgery due to the large size of the lesion (Figure 3a,b). A few 
weeks after surgery, a large fluctuant mass was seen at the surgical site, confirmed to be a 
pseudomeningocele on MRI. The pseudomeningocele continued to grow in size over a 
period of 6 months despite compression bandaging (Figure 3 c-e). Decision was hence 
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made for surgical intervention (aspiration of pseudomeningocele followed by duraplasty 
and cranioplasty).  
In the follow up MRI brain 1 month after surgery, a small residual area of sclerosis 
was seen within the left petrous temporal bone (Figure 4b), raising the diagnostic dilemma 
of reactive osseous sclerosis versus direct tumour infiltration, both of which can occur in 
MNTI. Follow up scan 1 year later showed interval reduction in the extent of bony sclerosis 
within the left petrous temporal bone (Figure 4c). This interval change is more suggestive 
of reactive sclerosis than residual tumour. 
 
Discussion 
Melanotic neuroectodermal tumour of infancy (MNTI) is an uncommon pigmented 
neoplasm of neural crest origin, first described in 1918. It is commonly seen in patients 
below the age of one. The majority of these cases occur within the maxilla and its 
occurrence in the cranial vault represents approximately 15.6% of cases 3,6. Within the 
cranial vault, most of these lesions are seen closely related to the cranial sutures and 
anterior fontanelle. Although it is generally agreed to be a benign entity, it is locally 
aggressive and has a rapid growth rate. Even after surgical resection, radiological follow 
up is recommended due to its significant recurrence rate, reported to be between 10-15%. 
Regional nodal metastasis is uncommon, seen in only approximately 7% of cases 7.  
On plain radiographs, MNTI is usually seen as a well circumscribed, expansile 
radiolucent lesion. Spiculated periosteal reaction can sometimes be observed 7. In our case, 
the lesion appeared as an ill-defined sclerotic lesion due to the predominant osseous 
changes of cranial vault thickening and reactive sclerosis. The presence of melanin in 
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MNTI is important as it defines the typical radiological appearances on CT and MRI. Due 
to the presence of melanin, the soft tissue component is typically mildly hyperdense on CT 
8. Enhancement is often present, as seen in our case. The bony changes range from cranial 
vault thickening with reactive sclerosis to spiculated periosteal reaction and osseous 
destruction. In our case, the soft tissue component is indeed mildly hyperdense on CT. Both 
cranial vault thickening with reactive sclerosis and spiculated periosteal reaction were seen. 
On MRI, hyperintense signal on T1-weighted images is characteristic of MNTI due to the 
T1 shortening effect of melanin, which enhances T1 relaxation 9. Melanin also accelerates 
T2 decay, resulting in hypointense signal on T2-weighted images. These typical MR signal 
characteristics are however not always present due to a multitude of factors, such as the 
density of melanin pigment within the tumour, presence of tumoral calcifications and 
reactive osseous sclerosis, both of which result in areas of decreased signal on T1- and T2-
weighted images. In our case, the soft tissue component of the mass demonstrates the 
typical signal pattern of melanin containing tumours, possibly related to the high density 
of melanin pigment. 
Cranial vault involvement in metastatic neuroblastoma is not uncommon, seen in 
up to 25% of cases 10. Neuroblastoma is the most common malignant metastasis to the skull 
in children 11. Typical imaging findings include spiculated periosteal reaction with or 
without associated osseous destruction. Soft tissue component often shows heterogenous 
avid enhancement. These imaging features are similar to those of MNTI. However, 
metastatic neuroblastoma usually show predominant hypointense signal on T1-weighted 
images. Occasionally, hyperintense signal may be seen on T1-weighted images due to the 
presence of haemorrhage or calcifications. Abdominal imaging is crucial to identify a 
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primary tumour site. MIBG (meta-iodobenzylguanidine) scan has a specificity of up to 
99% for neuroblastoma although up to 30% of neuroblastomas are not MIBG-avid. Urine 
homovanillic acid (HVA) and vanillymandelic acid (VMA) are elevated in more than 90% 
of cases. It is also important to note that cranial involvement of neuroblastoma rarely occurs 
in isolation. 
LCH is a spectrum of disease characterized by pathological proliferation of 
Langerhans-type histiocytes. The discovery of somatic activating BRAF mutations in a 
significant proportion of patients with LCH has opened the possibility of targeted inhibitor 
therapy 12. Cranial vault lesions of LCH are often seen as “punched-out” or geographic 
lytic bone lesions with bevelled edge and associated heterogeneously enhancing soft tissue 
component. Periosteal reaction and matrix calcifications are almost always absent in LCH, 
a useful imaging clue to differentiate it from MNTI and metastatic neuroblastoma. The 
presence of additional intracranial findings such as absent posterior pituitary “bright spot” 
and thickened pituitary stalk should also be sought for. A thickened enhancing pituitary 
stalk is the most common intracranial manifestation of LCH. If LCH is suspected, skeletal 
survey or radionuclide bone scan should be carried out to exclude multifocal disease, which 
has a worse prognosis. Unifocal lesion is treated with local curettage and intralesional 
corticosteroid injection. Radiation therapy is primarily reserved for recurrent disease. 
Primary Ewing sarcoma of the cranial vault is extremely rare, accounting for less 
than 1% of cases 13. The peak incidence is between the age of 5 and 13, slightly older 
compared to those with MNTI. Within the cranial vault, the temporal bone is the most 
common site of occurrence. On imaging, it is often seen as a destructive osseous lesion, 
with erosion of both the inner and outer tables. An associated soft tissue mass is usually 
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seen, predominantly within the epidural compartment. The presence of tumour matrix 
calcification is also a feature of Ewing sarcoma. Breaching of the dura and cerebral 
parenchymal invasion are rare 14. Primary cranial Ewing sarcoma has a relatively good 
prognosis, especially if diagnosed in the early stages and treated adequately. 
Intraosseous hemangiomas are slow-growing vascular tumours, commonly seen 
within the vertebral body and occasionally in the cranial vault (frequently within the 
parietal and frontal bones) 15–17. Patients typically present in adulthood with only few 
reported cases in infancy 15. On plain radiographs and CT, it is seen as a sharply marginated 
expansile lesion, with a sclerotic rim in 1/3 of cases. Osteoblastic remodelling with 
trabecular bone following osteoclastic activity of the tumour gives rise to the classical 
sunburst appearance on imaging 18. Unfortunately, this is not seen in all cases and its 
absence does not exclude the diagnosis of cavernous hemangioma. Associated bony 
erosion may be seen, especially in large lesions, more commonly affecting the outer table 
16. On MRI, intraosseous hemangioma display variable signal intensities, depending upon 
the quantity of slow-flow venous blood, trabecular bone and ratio of red marrow to 
converted fatty marrow 19. It is however usually heterogeneously hyperintense on T2-
weighted images (described as “light bulb bright”) and hypointense on T1-weighted 
images. Post contrast administration, diffuse heterogenous enhancement is seen with 
“filling-in” on delayed imaging. 
Solitary fibrous tumour/Hemangiopericytomas (SFT/HPC) are rare tumors that in 
most cases harbour a NAB2-STAT6 gene fusion 20. Intracranial infantile HPCs are 
extremely rare, accounting for less than 1% of all intracranial tumours and little is known 
about their prognosis or course. Infantile types, both peripheral and intracranial, have been 
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reported to have a less aggressive course compared to their adult counterpart 21. They are 
usually seen as well-demarcated multilobulated masses with heterogenous signal on MR 
imaging. They demonstrate predominant isointense signal on T1W and T2W images 22. On 
unenhanced CT, they are slightly hyperdense and may show osseous erosion, although 
matrix calcifications, hyperostosis and spiculated periosteal reaction are rare. 
Heterogeneous contrast enhancement is usually demonstrated on both CT and MRI22.  
 
CONCLUSION 
Although rare, MNTI should be in the list of differential diagnoses for rapidly growing 
cranial vault mass in infancy. Timely and accurate radiological diagnosis is crucial due to 
the rapid growth and locally invasive nature of the tumour. It is not always possible to 
make a definitive diagnosis on radiological grounds due to the variable imaging 
appearances of MNTI. However, when typical imaging features are present, a diagnosis 
can often be made. Hence, awareness of this rare entity and familliarity with its imaging 
features are crucial. This rare case of MNTI with concomitant involvement of the left 
cranial vault and petrous temporal bone also illustrates the diagnostic dilemma in 
differentiating reactive osseous sclerosis in surrounding bone (in this case, the left petrous 








1.  Borello ED, Gorlin RJ. Melanotic neuroectodermal tumor of infancy--a neoplasm 
of neural crese origin. Report of a case associated with high urinary excretion of 
vanilmandelic acid. Cancer 1966;19(2):196-206. 
2.  Andrade NN, Mathai PC, Sahu V, Aggarwal N, Andrade T. Melanotic 
neuroectodermal tumour of infancy - A rare entity. J Oral Biol Craniofac Res 
2016;6(3):237-240. doi:10.1016/j.jobcr.2016.06.005. 
3.  Cutler LS, Chaudhry AP, Topazian R. Melanotic neuroectodermal tumor of 
infancy: an ultrastructural study, literature review, and reevaluation. Cancer 
1981;48(2):257-270. 
4.  Latchaw RE, L’Heureux PR, Young G, Priest JR. Neuroblastoma presenting as 
central nervous system disease. AJNR Am J Neuroradiol 1982;3(6):623-630. 
5.  Zimmerman RA, Bilaniuk LT. CT of primary and secondary craniocerebral 
neuroblastoma. AJR Am J Roentgenol 1980;135(6):1239-1242. 
doi:10.2214/ajr.135.6.1239. 
6.  Rachidi S, Sood AJ, Patel KG, et al. Melanotic neuroectodermal tumor of infancy: 
A systematic review. J Oral Maxillofac Surg 2015;73(10):1946-1956. 
doi:10.1016/j.joms.2015.03.061. 
7.  Fowler DJ, Chisholm J, Roebuck D, Newman L, Malone M, Sebire NJ. Melanotic 
neuroectodermal tumor of infancy: clinical, radiological, and pathological features. 
Fetal Pediatr Pathol 2006;25(2):59-72. doi:10.1080/15513810600788715. 
8.  Chossegros C, Cheynet F, Gentet JC, Scheiner C. [Melanotic neuroectodermal 
tumor in an infant]. Arch Pediatr 1995;2(6):545-547. 
9.  Atkinson GO, Davis PC, Patrick LE, Winn KJ, Ball TI, Wyly JB. Melanotic 
neuroectodermal tumor of infancy. MR findings and a review of the literature. 
Pediatr Radiol 1989;20(1-2):20-22. 
10.  D’Ambrosio N, Lyo JK, Young RJ, Haque SS, Karimi S. Imaging of metastatic 
CNS neuroblastoma. AJR Am J Roentgenol 2010;194(5):1223-1229. 
doi:10.2214/AJR.09.3203. 
11.  Healy JF, Bishop J, Rosenkrantz H. Cranial computed tomography in the detection 
of dural, orbital, and skull involvement in metastatic neuroblastoma. J Comput 
Tomogr 1981;5(4):319-323. 
12.  Nelson DS, Quispel W, Badalian-Very G, et al. Somatic activating ARAF 
mutations in Langerhans cell histiocytosis. Blood 2014;123(20):3152-3155. 
doi:10.1182/blood-2013-06-511139. 
13.  Wang D, Guo Z. Multiple primary Ewing’s sarcomas in cerebral cranium of a 
child: a case report and review of the literature. Int J Clin Exp Pathol 
13		
2015;8(6):7575-7582. 
14.  Naama O, Ajja A, Gazzaz M, et al. [Primary Ewing sarcoma of the skull base with 
cerebral extension. A case report]. J Neuroradiol 2007;34(1):68-69. 
doi:10.1016/j.neurad.2007.01.004. 
15.  Honda M, Toda K, Baba H, Yonekura M. Congenital cavernous angioma of the 
temporal bone: case report. Surg Neurol 2003;59(2):120-3; discussion 123. 
16.  Koulouris G, Rao P. Multiple congenital cranial hemangiomas. Skeletal Radiol 
2005;34(8):485-489. doi:10.1007/s00256-004-0891-6. 
17.  Heckl S, Aschoff A, Kunze S. Cavernomas of the skull: review of the literature 
1975-2000. Neurosurg Rev 2002;25(1-2):56-62; discussion 66. 
18.  Liu JK, Burger PC, Harnsberger HR, Couldwell WT. Primary intraosseous skull 
base cavernous hemangioma: case report. Skull Base 2003;13(4):219-228. 
doi:10.1055/s-2004-817698. 
19.  Yalçin O, Yildirim T, Kizilkiliç O, et al. CT and MRI findings in calvarial non-
infectious lesions. Diagn Interv Radiol 2007;13(2):68-74. 
20.  Tai H-C, Chuang I-C, Chen T-C, et al. NAB2-STAT6 fusion types account for 
clinicopathological variations in solitary fibrous tumors. Mod Pathol 
2015;28(10):1324-1335. doi:10.1038/modpathol.2015.90. 
21.  Fernandez-Pineda I, Parida L, Jenkins JJ, Davidoff AM, Rao BN, Rodriguez-
Galindo C. Childhood hemangiopericytoma: review of St Jude Children’s Research 
Hospital. J Pediatr Hematol Oncol 2011;33(5):356-359. 
doi:10.1097/MPH.0b013e318214e667. 
22.  Chiechi MV, Smirniotopoulos JG, Mena H. Intracranial hemangiopericytomas: MR 








Figure 1:	Lateral (a) and frontal (b) skull radiographs showed a sclerotic lesion in the left 
parieto-occipito-temporal cranial vault. Computed tomography (CT) demonstrated	a 
solitary osseous-based lesion with marked spiculated periosteal reaction (c) and mildly 






Figure 2: On MRI, the soft tissue component showed mildly hypointense signal on T2-
weighted images (a) and hyperintense signal on T1-weighted images (b). Mass effect upon 
the underlying left temporo-parietal lobes was observed with mild vasogenic oedema 




Figure 3: The histology showed a tumour composed of three elements; small neuroblastic 







Figure 4:	A large calvarial defect was present after the surgery due to the large size of the 
lesion (a,b). Few weeks after surgery, a large fluctuant mass was seen at the surgical site, 
confirmed to be a pseudomeningocele on MRI. The pseudomeningocele continued to grow 





Figure 5. Coronal T2-weighted images (a) before surgery, (b) one month after surgery 
and (c) one year after surgery demonstrated an area of residual sclerosis within the left 
petrous temporal bone which subsequently showed interval reduction in extent on follow-
up at one year. Coronal computed tomography (CT) image (d) showed the area of 
residual sclerosis within the left petrous temporal bone one month after surgery.	
 
